Certify Before You Buy—How To Deal With New Machinery

Derek DeGeest, President of DeGeest Corporation and LestaUSA, knows when the industry comes together to help each other, successful integration of robotics and automation into operations follows. After being on both sides of the coin of installing a large finishing system and shepherding in new self-learning robotic technology to North America, it’s important to share the combined experiences of DeGeest Corp and LestaUSA to help manufacturing grow.

DeGeest wants to encourage other general industry manufacturers to bring new machinery into their operations. But, there is also a cautionary tale to be told. DeGeest shared his company’s ulcer-inducing experience and learnings when, as a contract job shop, they installed a large finishing system. A new state regulatory interpretation on machinery vs equipment almost shut down the entire system.

Without certification, the machinery was useless. “We had to find a way to learn the regulatory system and work with every group to find a solution,” DeGeest said. “And we did. Fast forward, three years later, we now have the largest robotic painting system in the contract job shop world in North America.”

DeGeest also walks through the process of getting Lesta’s robot technology NRTL certified and the importance of having this certification in North America. Launching Lesta’s proven robotic system’s in North America proved to need a different set of classifications than European standards that required multiple system changes.

DeGeest recognized when dealing with new machinery and equipment in the marketplace; regulators have an impossible task. “Changing technology in manufacturing is so fast that it doesn’t keep up with the code, and it is hard for them (the regulators) to interpret how they’re supposed to apply that to the new machinery that’s coming out,” DeGeest said. “That’s what happened to us. Our machinery was newly interpreted as equipment according to the codebook, so they didn’t know what to do.” DeGeest worked with the regulators to hammer out a solution, rewrite the code, and create a path forward for other industry companies. Why? Because at DeGeest Corporation and Lesta USA, they believe a rising tide lifts all boats.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

What the Future Looks Like if We Get It Right
What the Future Looks Like if We Get It Right
December 30, 2025

As the Patient Monitoring series concludes, the conversation shifts from today’s challenges to tomorrow’s possibilities. This final episode of the five-part Health and Life Sciences at the Edge series looks ahead to what healthcare could become if patient monitoring gets it right. Intel’s Kaeli Tully is joined by Sudha Yellapantula, Senior Researcher at Medical…

Read More
data center infrastructure
AI Is Forcing a Rethink of Data Center Infrastructure at Every Level
December 29, 2025

The data center industry is being redefined by AI’s demand for faster, denser, and more scalable infrastructure. According to McKinsey, average rack power densities have more than doubled in just two years. It went from approximately 8 kW to 17 kW, and is expected to hit 30 kW by 2027. Global data center power demand is projected…

Read More
Emergency department
How Predictive AI Is Helping Hospitals Anticipate Admissions and Optimize Emergency Department Throughput
December 24, 2025

Emergency departments across the U.S. are under unprecedented strain, with overcrowding, staffing shortages, and inpatient bed constraints converging into a throughput crisis. The American Hospital Association reports that hospital capacity and workforce growth have lagged, intensifying delays from arrival to disposition. At the same time, advances in artificial intelligence are moving from experimental to operational—raising…

Read More
Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More